Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Venée N Tubman"'
Autor:
Nicholas A. Ettinger, Danielle Guffey, Shaniqua J. Anum, Titilope Fasipe, Julie Katkin, Saleh Bhar, Gladstone Airewele, Arun Saini, Venée N. Tubman
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Data on outcomes and interventions for children with sickle cell disease (SCD) admitted to a pediatric intensive care units (PICU) are unknown. We provide the first comprehensive multi-center report on PICU interventions associated with deat
Externí odkaz:
https://doaj.org/article/cb90e9956bf44816a0a7a9dc582b21dd
Autor:
Kanagasabai Udhayashankar, Patience D Franklin, Cecelia J Nuta, Adolphus K Cherue, Heather Haq, Debbe Thompson, Venée N Tubman
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 4, p e0001705 (2023)
High-income nations have established that early diagnosis and preventive treatment reduces early deaths in sickle cell disease (SCD). However, in low-/middle-income countries where SCD is common, attrition from clinical care is common. Reasons for po
Externí odkaz:
https://doaj.org/article/288d27a7f13f4c78a51e12353063a148
Autor:
Mary Natoli, PhD, Megan Chang, BA, Kathryn Kundrod, PhD, Jackson Coole, BS, Gladstone Airewele, MD, Venée N Tubman, MD, Rebecca Richards-Kortum, PhD
Publikováno v:
The Lancet Global Health, Vol 9, Iss , Pp S13- (2021)
Background: Sickle cell anaemia is a common, life-threatening disorder caused by a point mutation in the β globin gene. The high cost and complexity of conventional diagnostic methods limit the scope and sustainability of newborn screening for sickl
Externí odkaz:
https://doaj.org/article/b47da340b6ec4186b6ca56bc59f6106d
Publikováno v:
Current Opinion in Hematology. 29:275-280
Low-income and middle-income countries (LMICs), primarily in sub-Saharan Africa (SSA), predominantly experience the burden of sickle cell disease (SCD). High frequency of acute and chronic complications leads to increased utilization of healthcare, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067b16fe64bebc7d2b78e857b939a2e0
https://doi.org/10.1097/moh.0000000000000738
https://doi.org/10.1097/moh.0000000000000738
Publikováno v:
Blood Journal.
Due to the unique biology of sickle cell disease, as well as the societal disadvantages and racial inequities suffered by these patients, individuals with sickle cell disease have not benefited from the same remarkable advances in care and therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b47e47307b2a70f281466ac985705ae
https://doi.org/10.1182/blood.2023020145
https://doi.org/10.1182/blood.2023020145
Publikováno v:
Hematology Am Soc Hematol Educ Program
The transfusion of red blood cells (RBCs) is a crucial treatment for sickle cell disease (SCD). While often beneficial, the frequent use of transfusions is associated with numerous complications. Transfusions should be offered with specific guideline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d60cf29101594c12695f52922e72f88
https://doi.org/10.1182/hematology.2021000307
https://doi.org/10.1182/hematology.2021000307
Autor:
Nancy S. Green, Andrew Zapfel, Obiageli E. Nnodu, Patience Franklin, Venée N. Tubman, Lulu Chirande, Charles Kiyaga, Catherine Chunda-Liyoka, Bernard Awuonda, Kwaku Ohene-Frempong, Baba P. D. Inusa, Russell E. Ware, Isaac Odame, Emmanuela E. Ambrose, Livingstone G. Dogara, Assaf P. Oron, Chase Willett, Alexis A. Thompson, Nancy Berliner, Theresa L. Coetzer, Enrico M. Novelli
Publikováno v:
Blood advances. 6(24)
Sickle cell disease (SCD) is a common condition within sub-Saharan Africa and associated with high under-5 mortality (U5M). The American Society of Hematology instituted the Consortium on Newborn Screening in Africa (CONSA) for SCD, a 7-country netwo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754303a6b926f666bb37a0c994a4ad34
https://pubmed.ncbi.nlm.nih.gov/36264096
https://pubmed.ncbi.nlm.nih.gov/36264096
Publikováno v:
Pediatric Hematology and Oncology. 36:382-389
This study compared outcomes following total (TS) or partial splenectomy (PS) among patients with hereditary spherocytosis. Seventy-nine patients (TS = 33, PS = 46) were identified. The follow-up p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b2b08b4d69e71358d35e0d2404ca100
https://doi.org/10.1080/08880018.2019.1637983
https://doi.org/10.1080/08880018.2019.1637983
Autor:
Patricia McQuilkin MD, Roseda E. Marshall MD, Michelle Niescierenko MD, Venée N. Tubman MD, Bradley G. Olson MD, Donna Staton MD, MPH, Jackson H. Williams MD, Elinor A. Graham MD, MPH
Publikováno v:
Global Pediatric Health, Vol 1 (2014)
This article describes a model employed by the Academic Collaborative to Support Medical Education in Liberia to augment medical education in a postconflict setting where the health and educational structures and funding are very limited. We effectiv
Externí odkaz:
https://doaj.org/article/cbaef145328c463daa31638812133c85
Autor:
Venée N. Tubman, Inga Hofmann, Ashley K. Koegel, Barbara A. Degar, Christine Duncan, Kristin Moffitt
Publikováno v:
Pediatric Blood & Cancer. 63:1844-1847
Patients with GATA2 haploinsufficiency have a significant predisposition to developing cytopenias, unique infectious manifestations, and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML). We report a unique case of a patient who presented wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91d1659729f13c7d3f00e638c22c686c
https://doi.org/10.1002/pbc.26084
https://doi.org/10.1002/pbc.26084